// App-Quantinova.ai

3596 : A prospective cohort study in colorectal cancer assessing the relationship between post-surgery detection of methylated BCAT1 or IKZF1 ctDNA and risk for residual disease and survival.

Researchers

Presenter

  • David Murray

Principal Investigators

  • Graeme P. Young

  • Susanne Kartin Pedersen

  • Philippa Rabbitt

  • Susan E Byrne

  • Kathryn J Cornthwaite

  • Amitesh Roy

  • Christos Karapetis

  • Erin L. Symonds

Medical Centers

  • Clinical Genomics Technologies Pty Ltd., North Ryde, Australia

  • Flinders Centre for Innovation in Cancer, Bedford Park, Australia

  • Flinders University Medical Centre, Adelaide, Australia

  • Flinders University Medical Centre, Adelaide, Australia

  • Repatriation General Hospital, Daw Park, Australia

Locations

  • Australia

Companies

  • ClinicalGenomics Pty

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved